Broadsheet number 48: Mercury, cadmium and arsenic: Toxicology and laboratory investigation

Pathology

Volumn 31, Issue 1, 1999, Pages 17-22

  Campbell, Bruce G ^a  

^a SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CADMIUM; MERCURY;

ARTICLE; INTOXICATION; PATHOLOGY; TOXICOLOGY;

EID: 0033048424     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130299105467     Document Type: Article

References (54)

1. Milne DB. Trace elements. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry. 2nd ed. Philadelphia: W B Saunders, 1994; 1317-53.
2. Standards Australia. AS 2636-1988, Sampling of venous blood for the determination of lead or cadmium concentration. Standards Association of Australia, 1988.
3. Klaasen CD. Heavy-metals and heavy-metal antagonists. In: Gilman AG, Rall TW, Nies AW, Taylor P, editors. The pharmacological basis of therapeutics. 8th. ed. New York: Pergamon, 1990; 1592-614.
4. Agency for Toxic Substances and Disease Registry. Mercury toxicity. Am Fam Phys 1992; 1731-41.
5. Slee PHThJ, den Ottolander GJ, de Wolff FA. A case of merbromin (Mercurochrome) intoxication possibly resulting in aplastic anemia. Acta Med Scand 1979; 205: 463-6.
6. Stanley-Brown EG, Frank JE. Mercury poisoning from application to omphalocele. J Am Med Assoc 1971; 216: 2144-5.
7. Margarey JA. Absorption of mercurochrome. Lancet 1993; 342: 1424.
8. Hammond AL. Mercury in the environment: natural and human factors. Science 1971; 171: 788-9.
9. Halbach S. Amalgam tooth fillings and man's mercury burden. Hum Exp Toxicol 1994; 13: 496-501.
10. Ellenhorn MJ, Barceloux DG. Medical toxicology. Diagnosis and treatment of human poisoning. New York: Elsevier, 1988; 1007-65.
11. Bakir F, Rustin H, Tikriti S, Al-Damluji SF, Shihristani H. Clinical and epidemiological aspects of methylmercury poisoning. Postgrad Med J 1980; 56: 1-10.
12. Waldren HA. Did the Mad Hatter have mercury poisoning? Br Med J 1983; 287: 1961.
13. Clarkson TW. Mercury - an element of mystery. New Engl J Med 1990; 332: 1137-9.
14. Elhassani SB. The many faces of methylmercury poisoning. J Toxicol Clin Toxicol 1982; 19: 875-906.
15. McAlpine D, Shukuro A. Minamata disease. An unusual neurological disorder caused by contaminated fish. Lancet 1958; ii: 629-31.
16. Grandjean P, Weihe P, White RF, Debes F, Arali S, Yokoyama K, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997; 19: 417-28.
17. Worksafe Australia. Guidelines for health surveillance NOHSC:7039(1995)]. Inorganic mercury. Worksafe Australia, 1995.
18. Sata F, Araki S, Yokoyama K, Murata K. Adjustment of creatinine-adjusted values in urine to urinary flow rate: a study of eleven heavy metals and organic substances. Int Arch Occup Environ Health 1995; 68: 64-8.
19. Araki S, Sata F, Murata K. Adjustment for urinary flow rate: an improved approach to biological monitoring. Int Arch Occup Environ Health 1990; 62: 471-7.
20. Perkin-Elmer FIAS-200 Flow Injection Atomic Absorption Spectrometry System Hardware Manual. Publication B3502, Release XPE. 03/12.89, Part No. B050-1666.
21. Welz B, Melcher M, Sinemus HW, Maier D. Picotrace determination of mercury using the amalgamation technique. Atom Spectrosc 1998; 5: 37-42.
22. Horvat M. Determination of methylmercury in biological certified reference materials. Water Air Soil Pollut 1991; 56: 96-102.
23. Liang L, Bloom NS, Horvat M. Simultaneous determination of mercury speciation in biological materials by GC/CVAFS after ethylation and room temperature precollection. Clin Chem 1994; 40: 602-7.
24. Lund ME, Berlin M, Clarkson TW, Banner W Jr. Treatment of acute methylmercury ingestion by haemodialysis with N-acetylcysteine (Mucomyst) infusion and 2,3-dimercaptopropane sulfonate. J Toxicol Clin Toxicol 1984; 22: 31-49.
25. Kostyniak PJ, Cunningham, E, Walshe J, Clarkson TW, Reddy P, Lachaal M, et al. Extracorporeal regional complexing hemodialysis treatment of acute inorganic mercury intoxication. Hum Exp Toxicol 1990; 9: 137-41.
26. Elinder CG. Health hazards from environmental or occupational exposure to cadmium. Acta Pharm Toxicol 1986; 59 Suppl 7: 24-30.
27. Lauwerys RR, Bernard AM, Roels HA, Buchet J-P Cadmium: exposure markers as predictors of nephrotoxic effects. Clin Chem 1994; 40: 1391-4.
28. Goering PL, Klaasen CD. Altered subcellular distribution of cadmium following cadmium pretreatment: possible mechanism of tolerance to cadmium-induced lethality. Toxicol Appl Pharmacol 1983; 70: 195-203.
29. Buchet JP, Lauwerys R, Roels H, Bernard A, Bruax P, Claeys F, et al. Renal effects of cadmium body burden of the general population. Lancet 1990; 336: 699-702.
30. Worksafe Australia. Guidelines for health surveillance [NOHSC: 7039 (1995)]. Cadmium. Worksafe Australia. 1995.
31. Tsuchiya K. Health effects of cadmium with special reference to studies in Japan. In: Nordberg GF, Herber RFM, Alessio L, editors. Cadmium in the human environment: Toxicity and carcinogenicity. Lyon: International Agency for Research on Cancer, 1992; 35-49.
32. Bernard A, Buchet JP, Cardens A, Lauwerys R. Cadmium and health. In: Nordberg GF, Herber RFM, Alessio L, editors. Cadmium in the human environment: toxicity and carcinogenicity. Lyon: International Agency for Research on Cancer, 1992; 15-33.
33. Standards Australia. AS 3503-1987. Whole blood-determination of cadmium-furance atomic absorption spectrometric method. Standards Association of Australia, 1987.
34. Standards Australia. As 4205.2-1994. Analysis of urine for trace elements. Part 2: Determination of copper, cadmium and lead-Flame atomic absorption spectrometric method. Standards Association of Australia, 1994.
35. Lopez-Artiguez M, Camean A, Repetto M. Preconcentration of heavy metals in urine and quantification by inductively coupled plasma atomic emission spectrometry. J Anal Toxicol 1993; 17: 18-22.
36. Schramel P, Wendler I, Angerer J. The determination of metals (antimony, bismuth, lead, cadmium, mercury, palladium, platinum, tellurium, thallium, tin and tungsten) in urine samples by inductively coupled plasma-mass spectrometry. Int Arch Occup Environ Health 1997; 69: 219-23.
37. Cullen WR, Reimer KJ. Arsenic speciation in the environment. Chem Rev 1989; 89: 713-64.
38. de Wolff FA, Edelbroek PM. Neurotoxicity of arsenic and its compounds. Handbook Clin Neurol 1994; 20: 283-91.
39. Buchet JP, Pauwels J, Lauwerys R. Assessment of exposure to inorganic arsenic following ingestion of marine organisms by volunteers. Environ Res 1994; 66: 44-51.
40. Greenwald J. Arsenic and old mines. Time 1995 (October 2); 58.
41. Le X-C, Cullen WR, Reimer KJ. Human urinary arsenic excretion after one-time ingestion of scaweed, crab and shrimp. Clin Chem 1994; 40: 617-24.
42. Aposhian HV. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 1997; 37: 397-419.
43. Schoolmeester WL, White DR. Arsenic poisoning. South Med J 1980; 73: 198-208.
44. Kleinfeld MJ. Arsine poisoning. J Occup Med 1980; 22: 820-1.
45. Hine CH, Pinto SS, Nelson KW. Medical problems associated with arsenic exposure. J Occup Med 1977; 19: 391-6.
46. Kasper ML, Schoenfeld L, Strom RL, Theologides A. Hepatic angiosarcoma and bronchioalveolar carcinoma induced by Folwer's solution. J Am Med Assoc 1984; 252: 3407-8.
47. Worksafe Australia. Guidelines for health surveillance [NOHSC: 7039 (1995)]. Inorganic Arsenic. Worksafe Australia, 1995.
48. Baselt RC, Cravey RH. Disposition of toxic drugs and chemicals in man. 3rd ed. Chicago: Year Book Medical Publishers, 1989; 65-9.
49. Standards Australia. AS 3502-1987, Urine - determination of total arsenic - furnace atomic absorption spectrometric method. Standards Association of Australia, 1987.
50. Jimenez de Blas O, Vicente Gonzalez S, Seisdedos Rodriguez R, Hernandez Mendez J. Determination and speciation of arsenic in human urine by ion-exchange chromatography/flow injection analysis with hydride generation/atomic absorption spectroscopy. J AOAC Int 1994; 77: 441-5.
51. Tracey ML, Moller G, Littlerfield ES. Continous flow vapour generation for inductively coupled argon plasma spectrometric analysis. Part 2. Arsenic. J AOAC 1991; 74: 516-21.
52. Apostoli P, Alessio L, Romeo L, Buchet JP, Leone R. Metabolism of arsenic after acute occupational arsine intoxication. J Toxicol Environ Health 1997; 52: 331-42.
53. Nixon DE, Moyer T. Arsenic analysis II: rapid separation and quantification of inorganic arsenic plus metabolites and arsenobetaine from urine. Clin Chem 1992; 38: 2479-83.
54. Muckter H, Fichtl B, Walther U, Hynder G, Reichl FX. Are we ready to replace dimercaprol (BAL) as an arsenic antidote? Hum Exp Toxicol 1997; 16: 460-5.